mRNA-2416-P101

Project: Research project

Project Details

Description

A Phase 1, Open-Label, Multicenter, Dose escalation study of mRNA-2416, a lipid nanoparticle encapsulated mRNA encoding human OX40L, for intratumoral injection to patients with advanced malignancies
StatusActive
Effective start/end date1/1/171/30/23

Funding

  • MODERNATX, INC.

Fingerprint Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.